PRAC recommends further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate medicine

View source ↗

Summary

PRAC recommends additional measures to reduce the risk of osteonecrosis of the jaw associated with bisphosphonate medicines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis-related Skeletal Complications
• Hypercalcemia of Malignancy
• Osteoporosis
• Paget Disease